Cost Effectiveness Of DTC Ads Varies In Securing Cancer Test Reimbursement
This article was originally published in The Gray Sheet
Executive Summary
Exact Sciences expects cost-effectiveness studies for the PreGen-Plus genomics-based colorectal cancer screening test to support relatively high reimbursement for the device